This week in health care trends, our big data in oncology spotlight includes articles that instruct us to “reuse and recycle”, GPS, recommendations from the Moonshot panel, and more. Cancer Cures Could Already Exist In Big Data “Reuse, and recycle” is a famous saying of the environmental movement, but cancer researchers might learn a thing […]
This week in health care trends, our big data in oncology spotlight includes articles that on the need to collect data from a large set of patient volunteers, how to encourage them to participate, and how our online search patterns give insight to diagnosing cancer. Uncle Sam Wants You — Or at Least Your […]
This week in health care trends, our big data in oncology spotlight includes: articles that discuss how continuing to collect data as technology improves expands understanding, corrects misunderstandings and provides new discoveries. Significant Expansion of Data Available In the Genomic Data Commons “This major infusion of data in the GDC will greatly enhance our ability […]
This week in health care trends, our oncology clinical pathways spotlight includes: the trouble with clinical pathways according to ASCO, why providing drugs in multiple vial sizes could actually save money, and one another reflects on VP Biden’s speech at ASCO.
President Obama appoints VP Joe Biden to lead a “moonshot” to cure cancer and Congress cares less about rising drug prices than the public does.
This week in healthcare, specialty drug spending is up 20% and the OMB has completed its regulatory review of the 340B “mega-guidance”
This week in health care trends, our oncology big data spotlight includes two companies who are leveraging big data to prevent hospital readmissions and unlock genetic cancer markers and a poll that suggests doctors are reluctant to share all health data with patients.
This week in healthcare, a look at UnitedHealth’s 700 TB database, which enables a variety of business intelligence, data mining and online analytical processing tools and BMS aims to bring to the first million-dollar-drug to the U.S. market.
This week in healthcare, an interview on the condition of U.S. cancer research and UnitedHealth’s $12.8 billion acquisition of pharmacy benefit manager Catamaran.
This week in healthcare, the New York Times compares U.S. and European drug costs and Express Scripts advocates for earlier involvement in the decision-making process to lower oncology drug costs.
Flatiron and NCCN Announce Cancer Quality and Outcomes Partnership and FDA Panel Recommends Approval of First Generic Biologic Drug
An FDA panel approves the first U.S. generic biologic drug and a study finds that if ACA subsidies were rescinded millions of Americans would lose coverage.
This week at the American Society of Hematology, a prominent oncology expert from M.D. Anderson Cancer Center weighs in on drug prices in the US.